{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:20Z","timestamp":1792784060905,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"MIUR FIRB 2010","award":["RBAP10447J_003"],"award-info":[{"award-number":["RBAP10447J_003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jbior.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T13:33:25Z","timestamp":1398864805000},"page":"6-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells"],"prefix":"10.1016","volume":"56","author":[{"given":"Alberto M.","family":"Martelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buontempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Tazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bressanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbior.2014.04.004_bib1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/ijc.23772","article-title":"Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2R \u03b3 null mice generate a faster and more efficient disease compared to other NOD\/scid-related strains","volume":"123","author":"Agliano","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jbior.2014.04.004_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/leu.2013.183","article-title":"Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts","volume":"28","author":"Agnusdei","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Aifantis","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbior.2014.04.004_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood.V94.5.1761","article-title":"Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic\/severe combined immunodeficient mice","volume":"94","author":"Ailles","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and propagating cells in leukaemia","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib6","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood-2008-02-138172","article-title":"NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity","volume":"113","author":"Armstrong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.pathmechdis.3.121806.154300","article-title":"Notch signaling in leukemia","volume":"3","author":"Aster","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jbior.2014.04.004_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2012.073585","article-title":"NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia","volume":"98","author":"Bandapalli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jbior.2014.04.004_bib10","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1073\/pnas.062050599","article-title":"Combined expression of pT\u03b1 and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis","volume":"99","author":"Bellavia","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbior.2014.04.004_bib11","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jbior.2014.04.004_bib12","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/leu.2012.116","article-title":"Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency","volume":"26","author":"Blackburn","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccr.2014.01.032","article-title":"Clonal evolution enhances leukemia-propagating ell frequency in T cell acute lymphoblastic leukemia through Akt\/mTORC1 pathway activation","volume":"25","author":"Blackburn","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.18632\/oncotarget.579","article-title":"Harnessing the PI3K\/Akt\/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels","volume":"3","author":"Bressanin","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2014.04.004_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/leu.2013.349","article-title":"Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling","volume":"28","author":"Buontempo","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/carcin\/bgt127","article-title":"The Notch signaling pathway as a mediator of tumor survival","volume":"34","author":"Capaccione","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jbior.2014.04.004_bib17","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1172\/JCI35090","article-title":"Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia","volume":"118","author":"Chiang","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jbior.2014.04.004_bib18","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","article-title":"Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia","volume":"69","author":"Chiarini","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib19","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"Chiarini","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib20","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1182\/blood-2010-06-292300","article-title":"Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance","volume":"116","author":"Chiu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ni1234","article-title":"Notch promotes survival of pre-T cells at the \u03b2-selection checkpoint by regulating cellular metabolism","volume":"6","author":"Ciofani","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbior.2014.04.004_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/IR:34:2:117","article-title":"A\u00a0survival guide to early T cell development","volume":"34","author":"Ciofani","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.20110105","article-title":"Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse","volume":"208","author":"Clappier","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib24","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1182\/blood-2004-03-0901","article-title":"Characterization of acute lymphoblastic leukemia progenitor cells","volume":"104","author":"Cox","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood-2006-06-030445","article-title":"Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia","volume":"109","author":"Cox","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2012.08.006","article-title":"Selective elimination of leukemia stem cells: hitting a moving target","volume":"338","author":"Crews","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jbior.2014.04.004_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nm.2610","article-title":"Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL","volume":"18","author":"Della Gatta","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1089\/scd.2012.0613","article-title":"Strategies for isolating and enriching cancer stem cells: well begun is half done","volume":"22","author":"Duan","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jbior.2014.04.004_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","article-title":"Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease","volume":"19","author":"Eisterer","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"Tan-1, the human homolog of the drosophila Notch gene, is broken by chromosomal translocations in T-lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/leu.2011.20","article-title":"Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia","volume":"25","author":"Evangelisti","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib32","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/scisignal.3135re5","article-title":"Phosphatidylinositol 3-kinase signaling in thymocytes: the need for stringent control","volume":"3","author":"Fayard","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.jbior.2014.04.004_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pbc.24803","article-title":"Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-all treated according to the NOPHO ALL-1992 and ALL-2000 protocols","volume":"61","author":"Fogelstrand","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jbior.2014.04.004_bib35","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2014.04.004_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature03589","article-title":"Notch signals control the fate of immature progenitor cells in the intestine","volume":"435","author":"Fre","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib37","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/leu.2013.156","article-title":"Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia","volume":"27","author":"Gachet","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543776.2014.859244","article-title":"BET bromodomain inhibitors: a patent review","volume":"24","author":"Garnier","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jbior.2014.04.004_bib39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/leu.2011.93","article-title":"Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations","volume":"25","author":"Gerby","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib40","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/nm.2960","article-title":"NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-\u03b8 and reactive oxygen species","volume":"18","author":"Giambra","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib41","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","article-title":"\u03b3-Secretase inhibitors and modulators","volume":"1828","author":"Golde","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jbior.2014.04.004_bib42","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1182\/blood-2008-08-174748","article-title":"Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL","volume":"113","author":"Gordon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/bjh.12511","article-title":"Very high frequencies of leukaemia-initiating cells in precursor T-acute lymphoblastic leukaemia may be obscured by cryopreservation","volume":"163","author":"Greystoke","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jbior.2014.04.004_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature06933","article-title":"Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation","volume":"453","author":"Guo","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1073\/pnas.1006937108","article-title":"Suppression of leukemia development caused by PTEN loss","volume":"108","author":"Guo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbior.2014.04.004_bib46","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20101691","article-title":"Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia","volume":"208","author":"Gutierrez","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib48","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/j.yexcr.2006.08.030","article-title":"SP analysis may be used to identify cancer stem cell populations","volume":"312","author":"Hadnagy","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib49","doi-asserted-by":"crossref","first-page":"22836","DOI":"10.1074\/jbc.M113.451625","article-title":"Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells","volume":"288","author":"Hales","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jbior.2014.04.004_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellsig.2013.09.021","article-title":"New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of \u03b3-secretase inhibitor resistant T-cell acute lymphoblastic leukemia","volume":"26","author":"Hales","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.jbior.2014.04.004_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib52","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.1320265111","article-title":"Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells","volume":"111","author":"Hoshii","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbior.2014.04.004_bib53","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jbior.2014.04.004_bib54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","article-title":"Glucocorticoid use in acute lymphoblastic leukaemia","volume":"11","author":"Inaba","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jbior.2014.04.004_bib55","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/0008-5472.CAN-08-2791","article-title":"Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy","volume":"69","author":"Indraccolo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib56","first-page":"53","article-title":"NOD\/Shi-scid IL2r \u03b3(null) (NOG) mice more appropriate for humanized mouse models","volume":"324","author":"Ito","year":"2008","journal-title":"Curr Top Microbiol"},{"key":"10.1016\/j.jbior.2014.04.004_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/leu.2012.176","article-title":"Impact of NOTCH1\/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial","volume":"27","author":"Jenkinson","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jbior.2012.10.001","article-title":"Deconstructing mTOR complexes in regulation of glioblastoma multiforme and its stem cells","volume":"53","author":"Jhanwar-Uniyal","year":"2013","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2014.04.004_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/leu.2009.209","article-title":"Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia","volume":"24","author":"Jotta","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib60","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1128\/MCB.02295-06","article-title":"Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death","volume":"27","author":"Kaminski","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jbior.2014.04.004_bib61","doi-asserted-by":"crossref","first-page":"1236566","DOI":"10.1126\/science.1236566","article-title":"mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin","volume":"341","author":"Kang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jbior.2014.04.004_bib62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/gcc.20684","article-title":"Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome","volume":"48","author":"Karrman","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jbior.2014.04.004_bib63","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","article-title":"Functional heterogeneity of genetically defined subclones in acute myeloid leukemia","volume":"25","author":"Klco","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ng.2913","article-title":"An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia","volume":"46","author":"Knoechel","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbior.2014.04.004_bib65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1242\/dev.080614","article-title":"Stem cells living with a Notch","volume":"140","author":"Koch","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.jbior.2014.04.004_bib66","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","article-title":"Notch in T-ALL: new players in a complex disease","volume":"32","author":"Koch","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jbior.2014.04.004_bib67","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1074\/jbc.M113.475376","article-title":"Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation","volume":"288","author":"Kong","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jbior.2014.04.004_bib68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A\u00a0cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib70","first-page":"1713","article-title":"Regulation of mTORC1 and its impact on gene expression at a glance","volume":"126","author":"Laplante","year":"2013","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jbior.2014.04.004_bib71","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1093\/nar\/gkm476","article-title":"The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor","volume":"35","author":"Lee","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib72","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20111470","article-title":"Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia","volume":"209","author":"Lee","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib73","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1182\/blood-2008-08-176016","article-title":"Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34\u2212 cell population with intrinsic resistance to imatinib","volume":"114","author":"Lemoli","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/156802608783334060","article-title":"Activity of \u03b3-secretase on substrates other than APP","volume":"8","author":"Lleo","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jbior.2014.04.004_bib75","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1084\/jem.20111855","article-title":"Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think","volume":"208","author":"Lobry","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib76","article-title":"Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia","author":"Lonetti","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib77","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/leu.2011.387","article-title":"Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development","volume":"26","author":"Luis","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib78","doi-asserted-by":"crossref","first-page":"e39725","DOI":"10.1371\/journal.pone.0039725","article-title":"NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches","volume":"7","author":"Ma","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.jbior.2014.04.004_bib79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.stem.2012.05.026","article-title":"Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression","volume":"11","author":"Magee","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib81","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2004-02-0514","article-title":"Mastermind critically regulates Notch-mediated lymphoid cell fate decisions","volume":"104","author":"Maillard","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.advenzreg.2011.09.019","article-title":"PI3K\/AKT\/mTORC1 and MEK\/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy","volume":"52","author":"Martelli","year":"2012","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2014.04.004_bib83","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/leu.2010.323","article-title":"Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells","volume":"25","author":"Masiero","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib84","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncb2037","article-title":"Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia","volume":"12","author":"Mavrakis","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jbior.2014.04.004_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/leu.2013.184","article-title":"Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention","volume":"28","author":"McCubrey","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2014.04.004_bib86","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2009-04-214718","article-title":"Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A\/ARF loss","volume":"115","author":"Medyouf","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib87","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20110121","article-title":"High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling","volume":"208","author":"Medyouf","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jbior.2014.04.004_bib90","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tem.2012.11.002","article-title":"PTEN in cancer, metabolism, and aging","volume":"24","author":"Ortega-Molina","year":"2013","journal-title":"Trends Endocrin Met"},{"key":"10.1016\/j.jbior.2014.04.004_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.blre.2010.09.004","article-title":"Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia","volume":"25","author":"Paganin","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.jbior.2014.04.004_bib93","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbior.2014.04.004_bib94","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib95","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib96","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","article-title":"Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia","volume":"24","author":"Piovan","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib98","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/0008-5472.CAN-12-1389","article-title":"Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias","volume":"73","author":"Rakowski","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbior.2014.04.004_bib99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"\u03b3-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/emmm.201201703","article-title":"Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations","volume":"5","author":"Rehe","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0092-8674(87)90667-2","article-title":"Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the \u03b2 T cell receptor gene in human lymphoblastic neoplasms","volume":"50","author":"Reynolds","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jbior.2012.10.005","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia","volume":"53","author":"Ribeiro","year":"2013","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2014.04.004_bib103","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood-2013-08-522698","article-title":"c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells","volume":"123","author":"Roderick","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons learned from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jbior.2014.04.004_bib105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejcb.2010.11.005","article-title":"The \u201cA Disintegrin And Metalloproteases\u201d ADAM10 and ADAM17: novel drug targets with therapeutic potential?","volume":"90","author":"Saftig","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jbior.2014.04.004_bib106","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-62703-481-4_2","article-title":"Production and characterization of humanized Rag2\u2212\/\u2212 \u03b3c\u2212\/\u2212 mice","volume":"1031","author":"Sanchez","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jbior.2014.04.004_bib107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.jbior.2014.04.004_bib108","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1586\/era.11.73","article-title":"Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises","volume":"11","author":"Sarmento","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jbior.2014.04.004_bib109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-pharmtox-010611-134717","article-title":"The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease","volume":"53","author":"Shanware","year":"2013","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/j.jbior.2014.04.004_bib110","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/MCB.01091-06","article-title":"Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc","volume":"26","author":"Sharma","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jbior.2014.04.004_bib111","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jbior.2014.04.004_bib112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","article-title":"Targeting Notch signaling pathway in cancer: clinical development advances and challenges","volume":"141","author":"Takebe","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jbior.2014.04.004_bib113","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2010-08-300343","article-title":"Notch1 inhibition targets the leukemia-initiating cells in a Tal1\/Lmo2 mouse model of T-ALL","volume":"118","author":"Tatarek","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib114","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","article-title":"Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34\u2212 fraction","volume":"115","author":"Taussig","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib115","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.advenzreg.2011.09.020","article-title":"Achieving specificity in Akt signaling in cancer","volume":"52","author":"Toker","year":"2012","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2014.04.004_bib117","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2040620712471368","article-title":"The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy","volume":"4","author":"Tosello","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jbior.2014.04.004_bib118","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult t-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jbior.2014.04.004_bib119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2014.04.004_bib120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nm1524","article-title":"Targeting the NF-\u03baB signaling pathway in Notch1-induced T-cell leukemia","volume":"13","author":"Vilimas","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib121","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1535-7163.MCT-10-0034","article-title":"Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design","volume":"9","author":"Wei","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jbior.2014.04.004_bib122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jbior.2014.04.004_bib123","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1074-7613(02)00330-8","article-title":"Inactivation of Notch1 impairs VDJ\u03b2 rearrangement and allows pre-TCR-independent survival of early \u03b1\u03b2 Lineage Thymocytes","volume":"16","author":"Wolfer","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jbior.2014.04.004_bib124","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2014.04.004_bib125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.smim.2010.04.015","article-title":"Notch regulation of early thymocyte development","volume":"22","author":"Yashiro-Ohtani","year":"2010","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jbior.2014.04.004_bib126","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbior.2014.04.004_bib127","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jbior.2014.04.004_bib128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492614000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492614000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:21:57Z","timestamp":1761949317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492614000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":128,"alternative-id":["S2212492614000062"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2014.04.004","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2014.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}